Department of Medical Oncology of Cancer Center, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu, 610041, China.
Department of Oncology, West China Fourth Hospital, West China School of Public Health, Sichuan University, Chengdu, China.
Ann Hematol. 2022 Jul;101(7):1545-1556. doi: 10.1007/s00277-022-04849-0. Epub 2022 May 30.
Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive disorder with heterogeneous clinical characteristics and poor prognosis. The combined value of baseline serum albumin level and absolute peripheral lymphocyte count showed prognostic information in a variety of malignancies, but its evidence is limited in ENKTL. The purpose of this study is to evaluate the impact of prognostic nutritional index (PNI) in ENKTL, and to provide some nutritionally and immunologically relevant information for better risk stratification. We conducted a retrospective study in 533 patients newly diagnosed with ENKTL. The PNI was calculated as albumin (g/L) + 5 × lymphocyte count (10/L). The optimal cutoff values for serum albumin and lymphocyte count were 40.6 g/L and 1.18 × 10/L, respectively, and 47.3 for PNI. After a median follow-up of 70 months, the 5-year overall survival (OS) and progression-free survival (PFS) were 56.2% and 49.5%, respectively. Patients in low PNI group had more unfavorable clinical features, and tended to have worse 5-year OS and PFS compared with those in high PNI group. According PNI-associated prognostic score, patients were classified into different risk groups. Significant difference has been found in 5-year OS and PFS in different risk groups. When PNI and PNI-associated prognostic score were superimposed on the International Prognostic Index (IPI), prognostic index of natural killer lymphoma (PINK), or nomogram-revised risk index (NRI) categories, the PNI and PNI-associated prognostic score provided additional prognostic information. Therefore, PNI and PNI-associated prognostic score could be independent prognostic factors for ENKTL and may be useful for risk stratification and clinical decision-making.
结外自然杀伤/T 细胞淋巴瘤(ENKTL)是一种具有异质性临床特征和预后不良的侵袭性疾病。基线血清白蛋白水平和绝对外周淋巴细胞计数的联合值在多种恶性肿瘤中显示出预后信息,但在 ENKTL 中的证据有限。本研究旨在评估预后营养指数(PNI)在 ENKTL 中的影响,并为更好的风险分层提供一些营养和免疫相关信息。我们对 533 例新诊断为 ENKTL 的患者进行了回顾性研究。PNI 计算为白蛋白(g/L)+5×淋巴细胞计数(10/L)。血清白蛋白和淋巴细胞计数的最佳截断值分别为 40.6 g/L 和 1.18×10/L,PNI 为 47.3。中位随访 70 个月后,5 年总生存率(OS)和无进展生存率(PFS)分别为 56.2%和 49.5%。低 PNI 组患者具有更多不利的临床特征,与高 PNI 组相比,5 年 OS 和 PFS 更差。根据 PNI 相关预后评分,患者被分为不同的风险组。不同风险组的 5 年 OS 和 PFS 存在显著差异。当 PNI 和 PNI 相关预后评分与国际预后指数(IPI)、自然杀伤淋巴瘤预后指数(PINK)或校正后的诺莫图风险指数(NRI)分类叠加时,PNI 和 PNI 相关预后评分提供了额外的预后信息。因此,PNI 和 PNI 相关预后评分可能是 ENKTL 的独立预后因素,可用于风险分层和临床决策。